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Carla Bonczak, BSN, RN
Introduction
Novel coronavirus (COVID-19) 
emerged late in 2019.  COVID-19 is 
known as a severe respiratory illness 
which is caused by a new coronavirus 
named severe acute respiratory 
syndrome coronavirus 2, or SARS-CoV-
2 (Shetty, 2020).  Since emergence, 
COVID-19 has become a pandemic 
illness that is easily spread through 
respiratory droplets from human to 
human (Shetty, 2020). In addition to 
severe respiratory illness, patients 
who contract COVID-19 may also 
experience complications such as 
cardiac arrhythmia, myocardial injury, 
kidney injury, shock, multiple organ 
dysfunction, and death in many 
instances (Shetty, 2019).  COVID-19 
has also been responsible for 
neurologic symptoms such as 
dizziness, headache, stroke, epilepsy, 
and impaired consciousness (Levy & 
Suarez, 2020). COVID-19 was chosen 
because it is a new illness that has had 
insurmountable effects throughout the 
world.  COVID-19 has disrupted every 
area of human normalcy, will go down 
in history, as well as recreate a new 
normal for daily living and medical 
care.
Signs & Symptoms
According to Liang and Acharya, 2020, 






• shortness of breath. 








• ALT, AST, LDH, ferritin, bilirubin, 
ammonia, myoglobin, creatinine 
kinase and cardiac troponin may 
also increase with tissue injury and 
as organs become affected (Levy & 
Sanchez, 2020)
• Individuals with COVID-19 may 
also experience a cytokine storm 
due to elevation of numerous 
proinflammatory cytokines which 
leads to:
o Edema
o Air exchange 
dysfunction
o Acute respiratory 
distress
o Secondary infection
o Potential death 
(Shetty, 2020)
• A cytokine storm happens because 
of “inflammatory mediators, 
monocytes, and macrophages 
activation of the inflammatory cell 
store lease proinflammatory (stress 
activated) cytokines (Li, et al, 2020)
• Activated cytokines in turn “act on 
leukocytes, lymphocytes, platelets, 
and vascular endothelial cells to 
secrete inflammatory mediators, 
which can increase blood C-reactive 
protein, a2-macroglobulin, and 
fibrinogen levels while decreasing 
albumin and transferrin levels”, (Li 
et al, 2020).  This process produces 
circulation to be in a high-output, 
low resistance state (Li, et at, 2020) 
• Once the inflammatory cytokines 
level reduces, the high output low 
resistance state as well as 
peripheral circulation are lightened 
and the blood circulation can return 
to normal which also reduces 
hypotension and tachycardia (Li, et 
al, 2020)
• Viral RNA has been detected in the 
urine and renal tissues of some 
patients positive for COVID-19 
further demonstrating negative 
effects from the virus (Murbank & 
Nasari, 2020)
• COVID-19 can adversely affect the 
central nervous system (CNS) by 
infecting the endothelial cells in the 
blood brain barrier or 
cerebrospinal fluid (Acarli et al, 
2020)
• Coronavirus belong to the 
Cornoviridae family and are 
“nonsegmented, enveloped, positive-
sense, single-strand ribonucleic acid 
viruses” (Kooraki et al, 2020) 
• According to Dr. Ashok Shetty 
(2020) “The pathogenesis of SARS-
CoV-2 has been suggested to include 
the recognition of the angiotensin I 
converting enzyme 2 receptor 
(ACE2) by its spike protein, and 
priming of its spike protein by the 
cellular transmembrane protease, 
serine 2 (TMPRSS2) facilitating host 
cell entry and spread (Shetty, 2020)
• ACE2 can be found in the heart, liver, 
kidney, and digestive organs (Shetty, 
2020).  Consequently, SARS-Co V-2 
can enter multiple organs and 
further extenuate the illness.  Some 
patients are requiring ICU care as the 
result of the spread and damage to 
multiple organs (Shetty, 2020)
• Persons who have been confirmed 
to have COVID-19 can suffer from 
acute respiratory distress syndrome 
and can require the need for 
additional oxygenation up to and 
including mechanical ventilation 
(Shetty, 2020) 
• Some patients are also experiencing 
further complications such as:  
o Myocardial injury
o Arrythmia
o Acute kidney injury
o Shock
o Death resulting from 
multiple organ 
dysfunction due to the 
SARS Co V-2 virus 
(Shetty, 2020)
• COVID-19 is a direct virus infection 
that “infects cardiomyocytes and 
replicates intracellularly” creating 
cardiomyocyte degeneration as well 
as necrosis that can result in loss of 
cardiac function and arrythmia (Li, et 
al, 2020)
• Limited vascular tone could be 
mistaken for vasculitis with 
hypercoagulability resulting from 
liver dysfunction and vascular 
endothelial (Levy & Suarez Sanchez, 
2020)
• D-dimer results can be used as an 
indicator of magnitude of disease 
that could signify disseminated 
intravascular coagulation (DIC) with 
a sudden increase in the marker 
(Levy, 2020)
COVID-19 is a novel virus that has 
spread throughout individuals 
worldwide and has been declared a 
national pandemic.  COVID-19 is spread 
through respiratory droplets from 
symptomatic as well as asymptomatic 
human carriers.  COVID-19 impairs 
breathing and can inflict complications 
that effect and damage multiple organs 
and can result in death.  Individuals, 
businesses, and educational systems 
have undergone major change in 
operations to fight against the spread of 
COVID-19. Hand hygiene, social 
distancing and proper use of PPE are the 
best defenses against COVID-19.  If 
patients require hospitalization, they 
must be placed in an isolation room and 
can struggle with being isolated from 
being able to leave their room or see 
family.  Currently, there is not a cure for 
COVID-19, but research, testing, and 
trials are being conducted to learn about 
COVID-19 and to discover treatment that 
could minimize the effects or cure 
COVID-19.
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Conclusion
Significance of Pathophysiology
• Currently there is not a cure or 
vaccination for COVID-19.  Several 
medications have been tested and 
have shown to improve symptoms in 
some instances, but not all
• If a patient requires hospitalization 
for COVID-19, they need to be 
admitted to a negative airflow room 
(Liang & Acharya, 2020)
• The best protection against COVID-19 
is regular hand hygiene, social 
distancing, and for medical staff-
wearing proper PPE when caring for 
this patient group (Shahid et al, 
2020)
• Care should be clustered, and 
exposure should be minimized
• If a patient needs to be transported 
throughout the hospital, they should 
wear a mask until returned to 
negative airflow room (Kooraki et al, 
2020)
• Patients are experiencing sadness 
and isolation as caregivers are afraid 
to go near them, family visitation is 
not allowed unless the patient is at 
the end of life, and patient’s must 
always remain in their room  with 
doors shut (Dhavale et al., 2020)
Figure 1.  (Center for Disease 
Control and Prevention, 2020)
Figure 3. Ronco, et at al, 2020
COVID-19 viral illness is caused by SARS Co V-2 virus. It is spread 
mostly via droplets within 3 feet of origin; however, the droplets could span out 
to 6 feet (Kooraki et al, 2020). The incubation period of COVID-19 is 2-14 days; 
however, an infected person can spread the illness via droplets prior to being 
symptomatic (Liang & Acharya, 2020).  Anyone at any age can become sick from 
COVID-19.  Senior citizens are more susceptible to COVID-19 and the many 
complications.  Patients who have pre-existing comorbidities such as 
hypertension, cardiovascular and/or cerebrovascular disease are at higher risk 
to develop a severe case of COVID-9 that may require ICU care (LI et al, 2020).  
Pregnant women are more susceptible to viral infections due to 
immune suppression; however, limited data suggests there may not be 
transplacental transmission to the unborn fetus (Liang & Acharya, 2020).  The 
disease process of COVID-19 is quite dynamic that can lead to shock as a result of 
ischemia and hypoxia in multiple organs and a reduction in circulation (Lin et al, 
2020).
Figure 2. (The Mercury News, 2020)
Figure 3.  (Ranco et al, 2020)
